Stocks · News reference
Inventiva Completes Final 72-Week NATiV3 Patient Visit With 1,419 Patients Enrolled, Topline Results Expected Q4 2026
Last patient completed final 72-week visit in NATiV3, with 1,009 patients enrolled in the main cohort and 410 patients in the exploratory cohortTopline results of NATiV3 expected in Q4 2026September investor conference
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Pinterest, Destiny Tech100 And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Monday. Shares of Pinterest, Inc. (NYSE:PINS) fell sharply in pre-market trading following the announcement that CFO Julia Brau
Inventiva Reports No Revenue During H1, Compared To €4.5M YoY